🇺🇸 FDA
Patent

US 12310943

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

granted A61KA61K31/352A61K31/366

Quick answer

US patent 12310943 (Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders) held by Amazentis SA expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amazentis SA
Grant date
Tue May 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/352, A61K31/366, A61K31/7048, A61K36/185